Comparison of MHC-incompatible intraportal islet and vascularized whole-pancreas transplantation in the prehyperglycemic phase of autoimmune diabetes.
Nakai
I
I
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Oda
T
T
Mitsuo
M
M
Shimizu
Y
Y
Arakawa
K
K
Oka
T
T
Sutherland
D E
DE
Brayman
K L
KL
D000375:Aging / Q000276:immunology / Q000502:physiology; D000818:Animals; D000831:Animals, Newborn; D001327:Autoimmune Diseases; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000276:immunology / Q000601:surgery*; D006650:Histocompatibility Testing; D006943:Hyperglycemia; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000502:physiology; D008285:Major Histocompatibility Complex; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D011169:Portal Vein; D011236:Prediabetic State / Q000276:immunology / Q000601:surgery; D051381:Rats; D011913:Rats, Inbred BB; D011917:Rats, Inbred Lew; D016042:Transplantation, Heterotopic
D001786:Blood Glucose